Science
Mechanism of Action
This advanced hyaluronic acid derivative functions as an exceptional radical scavenger, actively working to protect and prevent the degradation of the body's native hyaluronan molecules. Its unique structure provides significantly stronger antioxidant and anti-irritant effects compared to standard hyaluronates. Furthermore, its enhanced resistance to enzymatic hydrolysis ensures a prolonged and exceptionally long-lasting moisturizing presence on the skin.
Research
Clinical Evidence
Low confidenceN/A
Key findings
- 01 An in vitro study on hyaluronic-acid-butyric-ester derivatives, which includes components similar to Sodium Butyroyl Hyaluronate, evaluated their anti-proliferative activity in MCF7 cancer cells. The study indicated a progressive improvement in anti-proliferative effects with a degree of substitution up to 0.20 (corresponding to approximately 1.8-28.4% w/w), with effects diminishing beyond this point. This research focused on a specific cellular mechanism, rather than direct topical skin benefits.
- 02 Oral supplementation of standard Sodium Hyaluronate (1.8 MDa) at doses of 60 mg/day and 120 mg/day demonstrated improvements in skin hydration, elasticity, and reductions in transepidermal water loss (TEWL), sebum, and periorbital wrinkle depth in human subjects. The 120 mg/day dose showed more significant enhancements, including increased epidermal thickness and dermal density.
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Sodium Butyroyl Hyaluronate is sensitive to extreme pH levels. To maintain optimal efficacy, formulations should target a pH range of 5.0 to 7.5, as exposure to strong acids or bases can destabilize the ingredient and reduce its effectiveness. Viscosity of related hyaluronates is generally stable between pH 6.5 and 8.0.
Conflicts
- strong acids
- strong bases
- high concentrations of alpha hydroxy acids (AHAs)
- strong exfoliants
Safety
Safety Profile
Sodium Butyroyl Hyaluronate has not been individually reviewed by the Cosmetic Ingredient Review (CIR) Expert Panel. While the CIR has assessed related hyaluronates, such as Hyaluronic Acid and Sodium Hyaluronate, as safe for cosmetic use, this specific derivative lacks an explicit, standalone safety assessment. The FDA UNII record for Sodium Butyroyl Hyaluronate (2P689L1H2J) currently indicates a 'FAILED' status due to an 'incomplete polymer record', signifying a gap in its comprehensive regulatory data.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Sodium Butyroyl Hyaluronate presents a promising mechanism for enhanced moisturizing, antioxidant, and anti-irritant effects; however, direct topical human clinical data on its efficacy and optimal concentration are currently lacking for precise formulation guidance.
Related
Similar Ingredients
Finding similar ingredients…